# Federal Register #2026-19699

Proposed Pharmaceutical Production Activity at FTZ 57 for Eli Lilly and Company Drug Products

**Posted:** September 25, 2026
**Respond By:** November 04, 2026
**Identifier:** 2026-19699
**NAICS:** 325412, 325414, 325411

Eli Lilly and Company has notified the Department of Commerce, Foreign-Trade Zones Board of proposed production activity at FTZ 57 in Concord, North Carolina for a range of pharmaceutical products.
- Government Buyer:
  - Department of Commerce, Foreign-Trade Zones Board
- OEM/Vendor:
  - Eli Lilly and Company
- Products/Services Requested:
  - Incretin-based therapies for blood glucose and weight management
  - CGRP monoclonal antibodies for migraine prevention
  - IL-17A and IL-13 monoclonal antibodies for chronic inflammatory conditions and atopic dermatitis
  - IL-23-targeted therapies for inflammatory bowel disease
  - Amylin receptor-targeted therapies for weight management
  - Amyloid-targeted therapies for early Alzheimer's disease
  - Dosage/packaged forms include filled syringes, vials, delivery pens, and semi-finished syringes
  - Medicine delivery devices and parts (e.g., Cap Cartridge Holder, Dry Side Subassembly, Damping Cup, RNS Puller, Base Cap)
  - Needles, glass vials, and syringes
- Unique/Notable Requirements:
  - Use of foreign-status materials and components, some subject to duties under section 232 or 301 requiring privileged foreign status
  - No specific purchase quantities or part numbers provided
  - Public comment invited on proposed activity
- OEM Highlight:
  - Eli Lilly and Company is the sole manufacturer mentioned
- No services line items are specified
- Period of performance is not specified

### Description

Eli Lilly and Company has submitted a notification of proposed production activity at FTZ 57 in Concord, North Carolina, involving drug products. The proposed finished products include various drug therapies in dosage/packaged forms such as filled syringes, vials, or delivery pens. The notification details specific foreign-status materials and components used in production, some of which are subject to duties under trade laws. Public comments are invited until November 4, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/09/25/2026-19699/foreign-trade-zone-ftz-57-notification-of-proposed-production-activity-eli-lilly-and-company-drug)